1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,750 | 6,000 | 15:20 | |
| 5,750 | 5,950 | 15:20 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | What Made White Falcon Hold Lifecore Biomedical (LFCR)? | 1 | Insider Monkey | ||
| Fr | Lifecore Biomedical gets Nasdaq notice regarding delayed quarterly report | 1 | Seeking Alpha | ||
| Fr | Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report | 60 | GlobeNewswire (Europe) | CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the "Company") announced today that, on April 15, 2024, the Company received a notification letter (the... ► Artikel lesen | |
| Fr | LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report | 1 | SEC Filings | ||
| 08.04. | LIFECORE BIOMEDICAL, INC. \DE\ - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 01.04. | LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report | 1 | SEC Filings | ||
| 26.03. | Lifecore Biomedical, Inc.: Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update | 42 | GlobeNewswire (Europe) | CHASKA, Minn., March 26, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore" or the "Company"), a fully integrated contract development and manufacturing organization ("CDMO")... ► Artikel lesen | |
| 21.03. | Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal | 1 | Zacks | ||
| 20.03. | Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | 2 | Benzinga.com | ||
| 20.03. | CDMO Lifecore Biomedical names new CEO, board chair after year-long strategic review | 3 | FiercePharma | ||
| 20.03. | Lifecore Biomedical: Board Concludes Review; To Execute Strategic Plan As Standalone Company | 2 | RTTNews | ||
| 20.03. | Lifecore Biomedical concludes strategic evaluation process, names new CEO | 1 | Seeking Alpha | ||
| 20.03. | Lifecore Biomedical revises past financial statements | 3 | Investing.com | ||
| 20.03. | Lifecore Biomedical, Inc.: Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes | 1 | GlobeNewswire (USA) | ||
| 20.03. | Lifecore Biomedical, Inc.: Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023 | 291 | GlobeNewswire (Europe) | CHASKA, Minn., March 20, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"or the"Company"), a fully integrated contract development and manufacturing organization ("CDMO")... ► Artikel lesen | |
| 20.03. | LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report | 1 | SEC Filings | ||
| 16.02. | Lifecore faces potential Nasdaq delisting over filing delays | 2 | Investing.com | ||
| 16.02. | Lifecore Biomedical receives Nasdaq notice of delisting | 1 | Seeking Alpha | ||
| 16.02. | LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report | 1 | SEC Filings | ||
| 16.02. | Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal | 332 | GlobeNewswire (Europe) | CHASKA, Minn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the "Company") announced today that on February 13, 2024 it received a Staff Delisting Determination (the... ► Artikel lesen |
Seite:
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PVA TEPLA | 18,150 | -0,60 % | PVA Tepla-Aktie verliert 2,62 Prozent (17,50 €) | Im deutschen Wertpapierhandel notiert die PVA Tepla-Aktie derzeit ein wenig leichter. Der jüngste Kurs betrug 17,50 Euro. Die Aktie von PVA Tepla verzeichnet gegenwärtig einen Kursverlust von 2,62 Prozent.... ► Artikel lesen | |
| IROBOT | 6,328 | -0,94 % | iRobot: Aktie markiert neues Verkaufssignal | Die Aktie von iRobot hat zum Handelsstart am Montag nicht von der freundlichen Entwicklung an den US-Börsen profitieren können. Stattdessen geht es für das Papier weiter nach unten. Durch die anhaltende... ► Artikel lesen | |
| VA-Q-TEC | 23,200 | 0,00 % | Va-Q-tec Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| VECTRON | 7,700 | +2,67 % | Lok-Leasing: Kern vergrößert Vectron-Flotte | ||
| IDENTIV | 4,620 | -3,35 % | Identiv, Inc. - 8-K, Current Report | ||
| AXON ENTERPRISE | 280,00 | -0,99 % | Söllner: "Neue KI-Waffe" Nvidia, Xiaomi, "Fusionsreaktor!", Porsche-Wunder, Apple, Tesla, Kion, Axon | Florian Söllner, leitender Redakteur bei DER AKTIONÄR, blickt jede Woche auf die spannendsten Entwicklungen im Tech-Sektor. Heute geht es um folgende Werte: Nvidia, Bilfinger, Siemens Energy, Tesla... ► Artikel lesen | |
| AKER CARBON CAPTURE | 0,615 | -3,07 % | Aker Carbon Capture ASA: Aker Carbon Capture: Presentation of Q1 2024 results | OSLO, Norway, April 18, 2024 /PRNewswire/ -- Aker Carbon Capture ASA will present its first quarter 2024 results on 25 April 2024.
The presentation will be broadcast as an audiocast... ► Artikel lesen | |
| ZEBRA TECHNOLOGIES | 255,30 | -1,58 % | MASS Group Attains Zebra Technologies' Validation Certification for Its Premier Traceability Made Easy Software Solution | Traceability Made Easy® is now a Zebra Validated software, further elevating MASS Group's commitment to delivering high-quality inventory and asset management solutions with seamless integration.LAS... ► Artikel lesen | |
| SARTORIUS AG VZ | 286,90 | -2,08 % | Sartorius AG: Q1 24 results a mixed bag. 2024 outlook confirmed; mwb research confirms to SELL | Sartorius' Q1 revenues fell short of consensus, declining 8% yoy on a constant currency basis (c.c.), due to weakened demand in China and strong comps. Also order intake was a miss, while being up 8%... ► Artikel lesen | |
| MICROCLOUD HOLOGRAM | 2,350 | 0,00 % | MicroCloud Hologram Inc. - 6-K, Report of foreign issuer | ||
| EVOLV TECHNOLOGIES | 4,090 | 0,00 % | Evolv Technology Reports Record Fourth Quarter and Full Year Financial Results | WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based weapons detection to create safer experiences, today announced financial... ► Artikel lesen | |
| OSRAM | 51,00 | -0,39 % | MÄRKTE EUROPA/DAX bleibt in Rekordlaune - ASM-Osram mit Kurssturz | DJ MÄRKTE EUROPA/DAX bleibt in Rekordlaune - ASM-Osram mit Kurssturz
FRANKFURT (Dow Jones)--An den europäischen Aktienmärkten ging es auch am Donnerstag nach oben. Der DAX legte um 0,4 Prozent... ► Artikel lesen | |
| BYRNA TECHNOLOGIES | 12,870 | 0,00 % | Byrna Technologies Inc.: Byrna Technologies Reports Fiscal First Quarter 2024 Results | Revenue Increases by 98% Year-Over-Year to $16.7 Million
Company Achieves GAAP Profitability Following Continued Success of Celebrity Endorsement Strategy
ANDOVER, Mass., April 5, 2024 /PRNewswire/... ► Artikel lesen | |
| LUNA INNOVATIONS | 2,050 | 0,00 % | Luna Innovations restates certain financial statements | ||
| DRONESHIELD | 0,499 | -2,92 % | XFRA DRH: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILDRONESHIELD LTD... ► Artikel lesen |
LIFECORE BIOMEDICAL INC gehört der Branche Sonstige Technologie an. Die relative Kursveränderung beträgt aktuell -2,52 % bei einem Aktienkurs von 5,800 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
